에스디바이오센서

137310KOSPI의료용 기기 제조업

45.7 / 100

Reference Date: 2026-04-13

Financial Score15.0 / 40

News Sentiment17.7 / 25

Momentum6.0 / 20

Disclosure7.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Slightly up 1.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SD Biosensor, established in 2010, specializes in in-vitro diagnostics, offering products such as STANDARD Q, STANDARD F, and STANDARD E, which are known for high sensitivity and specificity. These products are used for rapid testing of various diseases, including COVID-19, and hold significant market share globally. The in-vitro diagnostics industry plays a crucial role in disease prevention and public health, with stringent regulations in major countries.

Number of Employees

656people

Average Salary

67.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 26.524.0Point

PBR

0.43Industry Average 1.707.0Point

Half of industry avg (excellent)

ROE

-19.49Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

18.81Industry Average 10.950.5Point

1.7x industry avg (risky)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲4.1% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲14.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -13.0% (declining, 3yr)

Detailed News Sentiment

13 totalPositive 7Neutral 2Negative 0Average Sentiment Score 80

Positive
에스디바이오센서, 광교에 R&D 센터 만든다
에스디바이오센서는 경기도 수원시 광교에 약 7426.2㎡ 규모의 '광교 R&D 센터' 구축을 추진하며, 그룹 통합 R&D 거점을 조성하여 신규 파이프라인 발굴을 체계화할 예정입니다.
Positive
에스디바이오, 광교에 R&D센터
에스디바이오센서는 광교에 R&D 센터를 건설하여 인체·동물 진단, 생명과학, 백신, 치료제 등 연구 기능을 집적하고 협업과 기술 융합 시너지를 추구하며 중장기 성장 기반을 강화할 계획입니다.
Neutral
'에테르노 청담' 보유세 2.7억→4.1억 … 내년엔 더 뛴다
올해 서울 공시가격 급등으로 강남3구와 한남·성수 등 초고가 단지들의 보유세 부담이 가파르게 뛰었으며, 세제 개편 시 세 부담이 더 늘어날 것으로 예상됩니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (19%, downtrend)

Current 8,200Won52-week high 12,07052-week low 7,260

1-month return3.0Point

1m 1.86% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

26 totalPositive 0Neutral 25Negative 1

Neutral[기재정정]정기주주총회결과2026-04-08
Neutral[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-04-08
Negative[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)2026-03-31
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
Neutral정기주주총회결과2026-03-26